To screen ETFs by asset class, performance, yield and more, check out the
This user currently has no profile.
I am a retired globetrotter and former financial manager with a Dow Jones Company. Some health issues, which are now very much "under control" and inspiration from key opinion leaders in the regenerative field, made me study the general theme of regenerative cell- and bio-materials technology for the past 8 years and invest in the sector according to my findings and learning's.
Stocks - long
Currently, there is no company profile for sheepshead.
The page where you can find all relevant information on Cytori Therapeutics Inc, listed on Nasdaq- Symbol-CYTX. From its history of becoming a listed Company on the Frankfurt Exchange under the symbol XMP, than named MacroPore Biosurgery, to the present, where Cytori is on the verge of becoming the first pure
stem cell company reaching profitability in a few quarters. But mainly you can find here information on its technology, partners and the HUGE future potential of the adipose derived regenerative cells (ADRC´s) platform technology, which potential is presently unfolding for anybody, that is willing to see it. Why? -simple- fat works and carries a strong efficacy signal in most therapeutic applications compared to other adult cell sources of the human body.
"doppelte unterschenkelfraktur"- double fibula/tibula breakage
You have to read the book - its in German though--------
Maybe this idea is not bad ...
Osiris - An Impressive Short Squeeze Leads To A...
Hi Brian-I fail to recogniz...
Cardiovascular Cell Therapies To Put Pressure O...
Your best article todate- c...
European Scandal Could Help Cytori Therapeutics
128 Mio portfolio value is ...
Accipiter Capital's Most Favorite Stock Picks
The facts in the article ar...
Cytori Gets FDA 510(k) Celution Clearance, Hear...
Xignite quote data
© 2014 Seeking Alpha